The Janus Henderson Horizon Biotechnology seeks capital appreciation by investing in a portfolio comprised primarily of global biotechnology companies
The Janus Henderson Horizon Biotechnology A2 Hedged (EUR) (Acc) is a(n) Equity Mutual Funds (MF) seeks to invest in Biotech sector located in Global. The Janus Henderson Investors fund’s base currency is USD and the share class was registered 25.02.2022 with unique ISIN - LU2441282972. The total expense ratio is 1.86%. The Janus Henderson Horizon Biotechnology A2 Hedged (EUR) (Acc) pays dividends 0 time(s) per year.